Coherus Oncology, Inc. (CHRS) Earnings Per Share (EPS)
Coherus Oncology, Inc. (CHRS) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$1.71 |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | $1.29 |
| 2020-12-31 | $1.85 |
| 2021-12-31 | -$3.81 |
| 2022-12-31 | -$3.76 |
| 2023-12-31 | -$2.53 |
| 2024-12-31 | $0.25 |
| 2025-12-31 | $1.43 |
How CHRS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ABEO | Abeona Therapeutics Inc. | $1.01 |
| NMTC | NeuroOne Medical Technologies Corporation | -$0.09 |
| INNV | InnovAge Holding Corp. | -$0.22 |
| DMAC | DiaMedica Therapeutics Inc. | -$0.70 |
| GOSS | Gossamer Bio Inc. | -$0.75 |
These are five companies in the same sector as CHRS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Coherus Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CHRS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CHRS | $1.20 | +0.00% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 |